Levetiracetam XR Tablet

Indication

Adjunctive therapy for the treatment of partial onset seizures

Product Advantage

Levetiracetam XR tablet with higher doses that provide a variety of options for clinical medication

Innovativeness

Special formulation technology

Product Introduction

Levetiracetam XR Tablet, developed based on the WrapMatrixTM  technology of the Group’s partner SPARC, is a novel extended-release tablet designed to have higher doses of levetiracetam (1000mg/1500mg). The product has been approved for marketing in the U.S.

With higher doses, Levetiracetam XR Tablet is expected to reduce pill burden and improve patient compliance.

Back